Lipocine (LPCN) Institutional Ownership → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free LPCN Stock Alerts $6.92 -0.01 (-0.14%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$362.22KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$3.71M Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023 EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% 5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023 Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022 Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022 Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022 EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022 Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021 Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021 Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021 Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021 State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021 Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021 LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021 Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021 Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021 XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021 BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021 Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023% 8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160% 5/19/2021 Virtu Financial LLC191,387$289K0.0%-8.0%0.217% 5/19/2021 Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095% 5/18/2021 Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063% 5/18/2021 Jane Street Group LLC29,060$44K0.0%N/A0.033% 5/17/2021 Price T Rowe Associates Inc. MD89,264$135K0.0%N/A0.101% 5/17/2021 Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795% 5/14/2021 MML Investors Services LLC41,000$62K0.0%N/A0.046% 5/14/2021 XTX Topco Ltd29,929$45K0.0%N/A0.034% Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024.5/13/2021 Barclays PLC21,594$33K0.0%N/A0.024% 5/12/2021 Northern Trust Corp148,222$224K0.0%+19.3%0.168% 5/12/2021 Geode Capital Management LLC603,713$911K0.0%+33.9%0.684% 5/11/2021 Mercer Global Advisors Inc. ADV211,210$319K0.0%-27.5%0.239% 5/10/2021 GSA Capital Partners LLP125,993$190K0.0%-32.3%0.143% 2/24/2021 Virtu Financial LLC207,996$283K0.0%N/A0.253% 2/12/2021 Mercer Global Advisors Inc. ADV291,210$396K0.0%+20.7%0.355% 2/11/2021 Northern Trust Corp124,210$169K0.0%+40.4%0.151% 2/9/2021 Bank of New York Mellon Corp60,886$83K0.0%N/A0.074% 2/5/2021 BlackRock Inc.1,618,913$2.20M0.0%+0.5%1.972% 2/4/2021 GSA Capital Partners LLP185,992$253K0.0%+133.0%0.227% 1/20/2021 Kestra Advisory Services LLC346,118$453K0.0%N/A0.527% 12/10/2020 Mercer Global Advisors Inc. ADV241,210$340K0.0%-11.3%0.367% 11/6/2020 BlackRock Inc.1,610,701$2.27M0.0%+122.7%2.452% 11/6/2020 GSA Capital Partners LLP79,817$113K0.0%+32.2%0.122% 8/12/2020 Goldman Sachs Group Inc.20,851$26K0.0%N/A0.044% 5/18/2020 Mercer Global Advisors Inc. ADV120,348$58K0.0%+71.1%0.251% 5/1/2020 BlackRock Inc.805,443$386K0.0%+4.1%1.683% (Data available from 1/1/2016 forward) LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: EP Wealth Advisors LLC ($13.40M), Aaron Wealth Advisors LLC ($116K), Virtu Financial LLC ($42K), Carson Advisory Inc. ($42K), Wealth Effects LLC ($41K), and Bailard Inc. ($32K), and Wealthspan Partners LLC ($29K).Learn more on LPCN's institutional investors. What percentage of Lipocine stock is owned by institutional investors? 9.11% of Lipocine stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine stock? The following institutional investors have purchased Lipocine stock in the last 24 months: Bailard Inc. ($157.36K), Virtu Financial LLC ($93.41K), Wealthspan Partners LLC ($73.95K), EP Wealth Advisors LLC ($66.98K), Carson Advisory Inc. ($52K), and Aaron Wealth Advisors LLC ($27.49K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 471,194 shares in the last 24 months. This purchase volume represents approximately $4.23M in transactions. Which Lipocine major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Wealth Effects LLC ($1.20M). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 1,201,195 shares in the last 24 months. This volume of shares sold represents approximately $6.24M in transactions. Related Companies: TNXP Major Shareholders LPTX Major Shareholders LTRN Major Shareholders MCRB Major Shareholders IMAB Major Shareholders CTMX Major Shareholders RPTX Major Shareholders SCPH Major Shareholders GOSS Major Shareholders RGLS Major Shareholders This page (NASDAQ:LPCN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
